PCR tests were used to assign genomovar status to 39 non-cystic fibrosis (non-CF) and 11 CF Burkholderia cepacia complex isolates from patients in hospitals in Recife, Brazil. Non-CF isolates were assigned to genomovar IIIA (71.8%), genomovar I (15.4%), B. vietnamiensis (7.7%), and B. multivorans (5.1%). CF isolates were assigned to genomovar IIIA (18.2%), B. vietnamiensis (18.2%), and genomovar I (9.1%). Six CF isolates sharing recA PCR-restriction fragment length polymorphism (RFLP) and randomly amplified polymorphic DNA (RAPD) patterns could not be assigned to a genomovar. 16S rDNA sequence obtained from these isolates indicated a closest relationship to B. anthina, but the recA sequence was equally divergent from several genomovars. PCR screening indicated the presence of cblA in only two isolates, whereas the B. cepacia epidemic strain marker was found in 22 of 28 genomovar IIIA isolates. A type III secretion gene was detected in all but genomovar I isolates. RAPD and PCR-RFLP assays, targeting both recA and fliC, indicated a large amount of genetic variability among the isolates, with many novel patterns being observed. Nine genomovar IIIA isolates from different non-CF patients and clinical sources had identical genotypes, indicating the presence of a common clone.Burkholderia cepacia is an important opportunistic respiratory pathogen, particularly in patients with cystic fibrosis (CF) (7) and chronic granulomatous disease (23). In addition, B. cepacia causes catheter-associated urinary tract infections, wound infections, intravenous catheter-associated bacteremia, and endocarditis (25,26).What is now known as the B. cepacia complex was subdivided by DNA-DNA hybridization, whole-cell protein pattern similarity, and phenotypic markers into five genomic species or genomovars (28) B. multivorans, genomovars IIIA and IIIB, B. stabilis, B. vietnamiensis, and B. ambifaria (15). Recently, a test for B. anthina has also been published (27).There have been a number of studies aimed at determining the distribution of genomovars among isolates from CF and non-CF patients (1, 2, 13, 24). In this paper, we report the application of PCR tests to the identification of 39 non-CF and 11 CF B. cepacia isolates from patients in hospitals in Brazil. We further report the results of PCR-based fingerprinting to determine genetic variability among the isolates and data concerning the distribution of genetic markers associated with cable pili, type III secretion (TTS), the B. cepacia epidemic strain marker (BCESM), and a putative polysaccharide export gene cluster.
MATERIALS AND METHODSBacterial strains. Thirty-nine non-CF isolates came from inpatients at neurological wards or intensive care units of Hospital Português, a large hospital facility in Recife, Brazil. Most patients were old debilitated individuals with respiratory problems and were undergoing ventilation. The CF isolates were recovered from 11 outpatients younger than 14 years, who were attending the CF unit of Instituto Materno Infantil de Pernambuco. All isolates...